Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Redox Reactions01:24

Redox Reactions

58.4K
Oxidation-reduction or redox reactions involve the transfer of electrons from one molecule or atom to another. When an atom gains an electron, another atom must lose an electron, meaning oxidation and reduction must occur together. Since the redox occurs in pairs, the atom that gets oxidized is also called the reducing agent or reductant, and the atom that is reduced is also called the oxidizing agent or oxidant. A straightforward way to remember the definitions of oxidation and reduction is...
58.4K
Redox Reactions01:27

Redox Reactions

928
Redox reactions are vital biochemical processes that underpin energy metabolism in cells. These reactions involve the transfer of electrons between molecules, occurring in tandem as oxidation and reduction. Oxidation refers to the loss of electrons, while reduction denotes their gain. This coupling ensures the seamless flow of electrons through metabolic pathways. For example, in bacterial metabolism, glucose undergoes oxidation to carbon dioxide, while oxygen is simultaneously reduced to...
928
Redox Titration: Other Oxidizing and Reducing Agents01:26

Redox Titration: Other Oxidizing and Reducing Agents

1.4K
Besides iodine, other oxidizing or reducing agents can serve as titrants in redox titrations. Common oxidizing titrants include KMnO4, cerium(IV), and K2Cr2O7. The choice of oxidizing titrants depends on factors like stability, cost, analyte strength, and reaction rate between the analyte and titrant. KMnO4 is a strong oxidizing titrant that reduces from Mn(VII) to Mn(II) in a highly acidic solution, simultaneously oxidizing the analyte to a higher oxidation state. In this case, KMnO4 acts as a...
1.4K
Balancing Redox Equations02:58

Balancing Redox Equations

61.7K
Electrochemistry is the science involved in the interconversion of electrical and chemical reactions. Such reactions are called reduction-oxidation, or redox reactions. These important reactions are defined by changes in oxidation states for one or more reactant elements and include a subset of reactions involving the transfer of electrons between reactant species. Electrochemistry as a field has evolved to yield sufficient insights on the fundamental principles of redox chemistry and multiple...
61.7K
Redox Equilibria: Overview01:23

Redox Equilibria: Overview

1.5K
A reduction-oxidation reaction is commonly called a redox reaction. In a redox reaction, electrons are transferred from one species to another rather than being shared between or among atoms. The reducing agent or reductant is the species that loses electrons and gets oxidized in the process. The species that gains electrons and gets reduced in the process is the oxidizing agent or oxidant. Redox reactions are represented as two separate equations called half-reactions, where one equation...
1.5K
Redox Titration: Overview01:21

Redox Titration: Overview

4.9K
Redox titration is a chemical analysis technique used to determine the concentration of an unknown substance by measuring the electron transfer in a redox (reduction-oxidation) reaction. The process involves gradually adding a titrant with a known concentration of an oxidizing or reducing agent, to the analyte, the solution with an unknown concentration, until reaching the endpoint, which indicates the completion of the reaction between the two substances. Ensuring the analyte is in a single...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet concentrates integrated with tissue engineering scaffolds: a promising approach for wound healing application.

Journal of nanobiotechnology·2026
Same author

Irofulven and RSL3 synergistically target ferroptosis-related gene PTGR1 to treat head and neck squamous cell carcinoma.

Open life sciences·2026
Same author

Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer.

ACS nano·2026
Same author

An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Versatile Eutectogel Sensor With Tunable Mechanical Properties for Monitoring of Human Bioelectromechanical Signals.

Small methods·2026
Same author

Microglia heterogeneity and therapeutic strategies in Parkinson's disease.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jan 21, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.9K

Cysteine-based redox-responsive nanoparticles for small-molecule agent delivery.

Liying Wang1, Xinru You2, Qi Lou3

  • 1Key Laboratory of Sensing Technology and Biomedical Instrument of Guangdong Province, School of Biomedical Engineering, Sun Yat-sen University, Guangzhou, Guangdong 510006, PR China. wujun29@mail.sysu.edu.cn and Research Institute of Sun Yat-Sen University in Shenzhen, Shenzhen, 518057, PR China.

Biomaterials Science
|August 8, 2019
PubMed
Summary

This study introduces a novel nanoparticle system for delivering small-molecule agents (SMAs) used in cancer therapy. The new system enhances drug bioavailability, reduces side effects, and improves anticancer treatment effectiveness.

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K
In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

4.8K

Related Experiment Videos

Last Updated: Jan 21, 2026

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
09:09

Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery

Published on: May 2, 2019

7.9K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.4K
In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System
06:45

In Vitro and In Vivo Delivery of Magnetic Nanoparticle Hyperthermia Using a Custom-Built Delivery System

Published on: July 2, 2020

4.8K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Small-molecule agents (SMAs) are crucial in molecular-targeted cancer therapies but often suffer from poor oral bioavailability and side effects due to low solubility.
  • Current oral administration limits the therapeutic efficacy and increases systemic toxicity of many SMAs.

Purpose of the Study:

  • To develop a biocompatible, redox-responsive nanoparticle (NP) delivery system for hydrophobic SMAs.
  • To improve SMA bioavailability, mitigate side effects, and enhance anticancer therapeutic performance.

Main Methods:

  • A cysteine-based hydrophobic polymer was used to create a redox-sensitive nanoplatform for hydrophobic SMAs.
  • Lapatinib-loaded nanoparticles (LAP-NPs) were synthesized and characterized for particle size and drug-loading capacity.
  • In vitro and in vivo studies were conducted to evaluate the anticancer potential of the developed SMA-NPs.

Main Results:

  • SMA-loaded nanoparticles (SMA-NPs) exhibited small particle size and high drug-loading capacity.
  • LAP-NPs demonstrated rapid redox-responsive drug release, enhanced in vitro cytotoxicity, and anti-metastasis properties.
  • In vivo studies showed preferential accumulation of LAP-NPs in tumor tissues and significant tumor growth suppression.

Conclusions:

  • The developed SMA-NP delivery system effectively improves the bioavailability and therapeutic performance of hydrophobic SMAs.
  • This nanoplatform holds significant potential for advancing molecular-targeted cancer therapies.